References
- Reed E, Janik J, Bookman M A. High dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in ovarian cancer patients. J Clin Oncol 1993; 11: 2127–2135
- Omadel D, Souhami R L, Whelan J, et al. Doxoreubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: Phase II trial of the European osteosarcoma intergroup. J Clin Oncol 1993; 12(9)1842–1848
- Chambers S K, Lamb L, Kohorn E L, Schwartz P E, Chambers J T. Chemotherapy of recurrent/advanced cervical cancer: The Yale University PBM-PSU protocol. Gynecol Oncol 1995; 53(2)161–169
- Rodrigues C I, Njo K H, Karim A B. Hypofractionation radiotherapy for a locally recurrent rectal carcinoma as a treatment for an elderly patient. Support Care Cancer 1993; 334–335
- Cox J D. Large-dose fractionation (hypo fractionation). Cancer 1985; 155(9 Suppl)2105–2111
- Coucke P A, Schmid C, Balmer A, Mirmanoff R O, Thames H D. Hypofractionation in retinoblastoma: An increased risk of retinopathy. Radiother Oncol 1993; 28(2)157–161
- Hall E J. Radiobiology for the Radiologist, 2nd ed. Harper & Row, Philadelphia 1978
- Rubin P, Constine L S, Fajardo L F, Phillips T L, Wasserman. Late Effects of Normal Tissues Consensus Conference. Int Radiat Oncol Biol Phys 1995; 31(5)1035–1364, (Special Issue)